BDNF-TrkB signaling in striatopallidal neurons controls inhibition of locomotor behaviour. by Besusso,  D. et al.
Durham Research Online
Deposited in DRO:
13 August 2014
Version of attached ﬁle:
Published Version
Peer-review status of attached ﬁle:
Peer-reviewed
Citation for published item:
Besusso, D. and Geibel, M. and Kramer, D. and Schneider, T. and Pendolino, V. and Picconi, B. and
Calabresi, P. and Bannerman, D.M. and Minichiello, L. (2013) 'BDNF-TrkB signaling in striatopallidal
neurons controls inhibition of locomotor behaviour.', Nature communications., 4 . p. 2031.
Further information on publisher's website:
http://dx.doi.org/10.1038/ncomms3031
Publisher's copyright statement:
This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. To view a copy of this licence
visit http://creativecommons.org/licenses/by/3.0/.
Additional information:
Use policy
The full-text may be used and/or reproduced, and given to third parties in any format or medium, without prior permission or charge, for
personal research or study, educational, or not-for-proﬁt purposes provided that:
• a full bibliographic reference is made to the original source
• a link is made to the metadata record in DRO
• the full-text is not changed in any way
The full-text must not be sold in any format or medium without the formal permission of the copyright holders.
Please consult the full DRO policy for further details.
Durham University Library, Stockton Road, Durham DH1 3LY, United Kingdom
Tel : +44 (0)191 334 3042 | Fax : +44 (0)191 334 2971
http://dro.dur.ac.uk
ARTICLE
Received 17 Sep 2012 | Accepted 17 May 2013 | Published 18 Jun 2013
BDNF–TrkB signaling in striatopallidal neurons
controls inhibition of locomotor behavior
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The physiology of brain-derived neurotrophic factor signaling in enkephalinergic striatopallidal
neurons is poorly understood. Changes in cortical Bdnf expression levels, and/or impairment
in brain-derived neurotrophic factor anterograde transport induced by mutant huntingtin
(mHdh) are believed to cause striatopallidal neuron vulnerability in early-stage Huntington’s
disease. Although several studies have conﬁrmed a link between altered cortical brain-
derived neurotrophic factor signaling and striatal vulnerability, it is not known whether the
effects are mediated via the brain-derived neurotrophic factor receptor TrkB, and whether
they are direct or indirect. Using a novel genetic mouse model, here, we show that selective
removal of brain-derived neurotrophic factor–TrkB signaling from enkephalinergic striatal
targets unexpectedly leads to spontaneous and drug-induced hyperlocomotion. This is
associated with dopamine D2 receptor-dependent increased striatal protein kinase C and
MAP kinase activation, resulting in altered intrinsic activation of striatal enkephalinergic
neurons. Therefore, brain-derived neurotrophic factor/TrkB signaling in striatopallidal neurons
controls inhibition of locomotor behavior by modulating neuronal activity in response to
excitatory input through the protein kinase C/MAP kinase pathway.
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D
istinct basal ganglia (BG) circuits involved in motor
control (direct and indirect pathways), originate in the
dorsal striatum. These receive convergent excitatory
afferents from the cortex and thalamus. The direct striatonigral
pathway activity induces disinhibition of excitatory thalamocortical
projections and facilitation of movement. The indirect striatopallidal
pathway induces inhibition of thalamocortical projection
neurons, which decrease cortical premotor drive and inhibit
movement1,2. Preferential loss of the indirect pathway medium-
sized spiny neurons (MSNs) is thought to decrease the amount
of inhibitory control over unwanted movements, leading to
chorea and hyperkinesia typically associated with deﬁne HD:
Huntington’s disease (HD) (ref 3). HD is an autosomal dominant
and progressive neurodegenerative disorder characterized by
severe deﬁcits in motor function, cognitive and psychiatric
changes. This disorder is correlated with an expansion of a CAG
repeat at the N-terminal region of the huntingtin gene4.
Although the exact mechanism by which mHdh causes
neuronal dysfunction is not yet established, it is clear that regions
of the brain such as the striatum are the ﬁrst to degenerate.
Previous studies at early stages of the disease demonstrate that
striatal enkephalinergic (ENK)-positive GABAergic medium
spiny neurons projecting to the external part of the globus
pallidus are more vulnerable than the striatal MSN subset
expressing substance P, an effect also found in HD mouse
models5–8. These neurons, also known as striatopallidal neurons,
coexpress the dopamine receptor 2 (D2R)9. Their degeneration in
HD ultimately results in the loss of inhibitory input to the
thalamus, enhancing involuntary movements (chorea)10. The
mechanisms that drive selective striatal cell loss are currently
unclear and still extensively investigated. A recent hypothesis
suggests that mHdh drives a progressive decline in striatal trophic
support that ultimately leads to MSNs degeneration, initially of
ENK–MSNs11. The neurotrophic brain-derived neurotrophic
factor (BDNF) appears to be indispensable for striatal cell long-
term survival and maintenance. Cortical neurons are the main
source of striatal BDNF, which is delivered by anterograde
transport through the corticostriatal afferents12. Mutant Hdh
impairs BDNF promoter II transcriptional activity through the
cytoplasmic retention of the neuron-speciﬁc transcriptional
repressor REST11, and can also interfere with BDNF anterograde
transport from cortical neurons to striatal targets13. Therefore,
reduction in BDNF supply to the striatum jeopardizes the long-
term survival and morphology of striatal MSNs14,15, contributing
ultimately to striatal degeneration in HD. This is consistent with
the reduced cortical and striatal BDNF levels observed in both HD
patients and mouse models16. Forebrain-speciﬁc Bdnf mutants
recapitulate many behavioral and anatomical abnormalities seen in
mouse models of HD14. Similarly, mice carrying mHdh transgene,
with genetic reduction of BDNF levels, exhibit advanced onset and
increased severity of motor dysfunction, resulting from the
degeneration of striatal ENK–MSNs5.
Despite extensive evidence associating cortical Bdnf levels with
striatal vulnerability, there is no demonstration that these effects
are mediated via TrkB. This is mainly due to any ablation or
alteration of Bdnf levels, either globally or in a region-speciﬁc
manner, affecting cortical physiology17, and therefore confounding
the action of Bdnf anterogradely transported from the cortex to
other regions of the brain, such as its striatal targets.
To address the physiological role of BDNF/TrkB signaling in
striatopallidal neurons, we have selectively deleted the high-
afﬁnity BDNF receptor, TrkB, from ENKþMSNs. Surprisingly,
this manipulation led to spontaneous and drug-induced hyperlo-
comotion associated with increased D2R-dependent MAPK/PKC
phosphorylation and reduced striatopallidal activation, without
obvious effects on motor coordination and gait parameters, or
long-term survival and morphological defects of ENKþMSNs.
We therefore demonstrate that BDNF–TrkB signaling in striatal
ENKþMSNs contributes to the inhibitory control of locomotor
behavior exerted by the indirect pathway.
Results
Generation of Enkephalin-speciﬁc Trkb knockout mice. To
address the physiological relevance of BDNF–TrkB signaling in
the ENKþMSNs, we conditionally deleted Trkb from these
neurons by generating a BAC transgenic mouse line carrying
Cre-recombinase under the control of the pre-proenkephalin
promoter (BAC–Penk–Cretg/þ ) (Supplementary Fig. S1a). We
studied the recombination pattern of the BAC–Penk–Cre line
using two reporter lines18,19 (Fig. 1a–c), which recapitulated
mostly the expression of the pre-proenkephalin gene reported
in literature20. Namely, recombination was detected in particular
in the caudate-putamen, the nucleus accumbens, scattered cells in
cortical layer II and V–VI (Fig. 1a), and the granular layer of
the olfactory bulb and cerebellum. The cellular speciﬁcity of
Cre-recombination was examined by double immunoﬂuorescence
using antibodies (Abs) to YFP and to markers either speciﬁc for
ENKþMSNs, showing Cre-mediated EYFP expression occurring
in 98% of the ENKþMSNs (Fig. 1b), or speciﬁc for striatal
interneurons, showing no colocalisation (Fig. 1c). The relative
abundance of EYFPþMSNs within the striatum was estimated
using COUPTF1-interacting protein 2 (CTIP2) (ref. 21). We found
40–50% EYFPþMSNs (Supplementary Fig. S1b), consistent with
the literature22. However, 4% of the total EYFPþ cells do not
express enkephalin. Possibly the enkephalin-promoter was active
at some point during cell differentiation or expression of
enkephalin is below the minimum detectable level. This novel Cre
line was crossed to a Trkb ﬂoxed line23 to generate TrkbPENK-KO
mice. E(Y)GFP immunoreactivity was not detected in the developing
mouse brain before E12.5, consistent with enkephalin expression in
differentiating multipotent progenitors but not in earlier progenitors,
unlike Dlx5 (refs. 20,24) (Fig. 1d–g). Western blot analysis of adult
mouse brain lysate further conﬁrmed speciﬁc striatal TrkB reduction
in TrkbPENK-KO mice compared with Cre-negative TrkbPENK-WT
littermates (Trkblx/lx;PENKþ /þ ) (Fig. 1h). Trkb deletion
was also validated by in situ hybridization combined with
immunoﬂuorescence double staining (Trkb/EYFP), (Supplementary
Fig. S1c). These data conﬁrmed the speciﬁcity and successful
inactivation of Trkb in ENKþ neurons.
Trkb deletion in ENK MSNs results in hyperlocomotion.
Recent work, by toxin ablation or functional disruption of the
striatopallidal D2R neurons, has provided direct evidence that
these neurons regulate inhibitory functions on locomotor activ-
ity25,26. To understand if BDNF–TrkB signaling would be
relevant to this function, we tested locomotor activity of
TrkbPENK-KO mice and age-matched TrkbPENK-WT in the open-
ﬁeld (OF) apparatus (Fig. 2a,b). We found a sharp signiﬁcant
increase in total distance traveled in TrkbPENK-KO mice compared
with that in TrkbPENK-WT littermates by 9M of age until later in
life (Fig. 2a). The TrkbPENK-KO spontaneous hyperlocomotion
observed in the OF cannot be due to increased anxiety or general
activity of the mice, as analysis of time spent in the border
compared with that in the center of the OF apparatus, and
analysis of home-cage activity over 3 days did not reveal
signiﬁcant differences between genotypes (Supplementary Fig.
S2a,b). Mice carrying only the Cre transgene tested at 9M of age
in an OF did not show signiﬁcant changes compared with wild-
type mice (P¼ 0.897, unpaired Student’s t-test), conﬁrming that
the spontaneous increased locomotion observed in the TrkbPENK-
KO mice was due to the speciﬁc deletion of Trkb in ENKþMSNs.
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Drugs of abuse, like cocaine, are able to induce hyperlocomo-
tion, an action that is largely mediated through the striatum27.
As the hyperlocomotion phenotype observed in the OF is age-
dependent, it is likely that young mice already have a mild defect
in motor control that is not detectable in a paradigm of
spontaneous locomotion. Therefore, we tested the response of
young adult (3M old) TrkbPENK-KO and TrkbPENK-WT mice in the
OF when acutely challenged with cocaine. TrkbPENK-KO mice
showed signiﬁcantly increased distance traveled compared with
TrkbPENK-WT littermates upon cocaine treatment (Fig. 2b),
demonstrating that lack of BDNF–TrkB signaling in ENKþMSNs
enhances cocaine-induced hyperlocomotion. This conﬁrms that
striatopallidal neurons lacking BDNF–TrkB signaling lose
inhibitory control over locomotor activity, and that young
mutants show a phenotype similar to the aged one if challenged.
To assess if lack of TrkB signaling in ENKþMSNs would affect
motor coordination and overall motor function, we ﬁrst
examined TrkbPENK-KO mice and TrkbPENK-WT littermates for
clasping, and found normal hind-paw clasping in both genotypes
at all stages analyzed. We then assessed motor coordination
performance of TrkbPENK-KO using the rotarod test. Twenty-ﬁve
TrkbPENK-WT and 25 TrkbPENK-KO mice from 2 to 14M of age
were tested. Mutants showed similar performance compared with
control littermates (Fig. 2c), indicating that lack of BDNF–TrkB
signaling in striatopallidal ENKþMSNs does not affect general
performance in motor coordination.
Subtle gait differences in TrkbPENK-KO mice. As neither the OF
nor the rotarod test would allow for objective assessment and
quantitative measures of ﬁne motor movements, we then used the
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Figure 1 | Generation of Trkb-enkephalin knockout mice. (a) Adult brain image of BAC–Penk–Cretg/þ ::Z/EG–egfptg/þ mouse stained with G(Y)FP Abs
revealing Cre-mediated GFP expression in speciﬁc brain areas, the caudate-putamen (CPu), the nucleus accumbens (NAc), scattered cells in cortical layer II
and V–VI (CX). (b) Confocal images showing Cre-mediated EYFP expression in ENK striatal cells, (c) and absence of EYFP expression in striatal interneurons
(arrows) identiﬁed by speciﬁc markers. (d,e) Dlx5 in situ expression at E11.5 in the striato-pallidal neural ephitelium (stiatal-ne, pallidal-ne), and absence of
Penk1 expression in the same regions at this stage (images are from the Allen Mouse Brain Atlas20). (f) E11 BAC–Penk–Cretg/þ ::Z/EG–egfptg/þ
transversal brain section with no GFP staining in the striato-pallidal neural ephitelium. (g) PCR analysis of Trkb recombination in brains carrying the
BAC–Penk–Cre transgene at E12.5. Primers were speciﬁc for un-recombined (Nr) and recombined (r) Trkblx allele; each embryo carried a Trkblx allele
and TrkbWT allele. Recombination occurred only in presence of the Cre transgene (embryos 1–3). (h) Protein lysates from different brain regions of adult
Trkblx/lx mice either in presence (þ ) or in absence ( ) of the Cre transgene were analyzed for TrkB protein levels. Blots were probed with Abs to
p145-TrkB. Striatal TrkB levels were 50% reduced, but unchanged in the cortex. Blots were reprobed with Abs to TUJ.1 to control for loading and
quantiﬁcation of fold changes (values are mean±s.d.). ChAT, choline acetyltransferase. Scale bars: a, 500 mm; b,c, 50 mm; f, 100 mm. See also
Supplementary Fig. S1.
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CatWalk test; a new method of quantitative gait analysis28,29.
This method allows easy quantiﬁcation of a large number of
locomotion parameters during walkway crossing (Supplementary
Methods). This test has also been validated to study motor
impairment associated with different neurological motor
disorders, including an HD model30. Analysis of mice at 5M
of age, before mutants develop spontaneous hyperlocomotion,
revealed no signiﬁcant differences between genotypes in activity-
related parameters (Supplementary Table S1). All parameters
related to single paws, previously reported to be compromised in
a transgenic rat model of HD30, were normal in TrkbPENK-KO
mice compared with that in controls (Supplementary Fig. S3a–d,
Supplementary Table S2). However, a smaller print width for the
left hind paw (LH) was found in mutant mice compared with that
in controls (Supplementary Fig. S3e, Supplementary Table S2).
There was no difference between genotypes in front-paw
parameters (Supplementary Table S2).
As for the coordination-related gait parameters, both mutant
and control mice showed normal interlimb coordination based on
the analysis of the step sequence patterns, and normal phase
dispersion (Supplementary Table S3, Supplementary Fig. S4).
However, some differences between genotypes were found in the
time relationship between footfalls of two different paws
(couplings), with slightly decreased timely coordination between
ipsilateral (RH-RF) and girdle paws (RH-LH), but slightly
increased coordination between diagonal paws (RF-LH) in
TrkbPENK-KO mice compared with that in controls (Supplementary
Fig. S3f-g).
Mice examined in the CatWalk test were additionally analyzed
in the inverted screen test, which requires motor coordination
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mutant mice tested as independent groups at different stages (TrkbPENK-WT, n¼9, 9, 7; TrkbPENK-KO, n¼ 7, 9, 7, for the three groups, respectively). Mice
were individually placed into an OF arena for 30min and the distance traveled was recorded. While no difference was observed up to 8M of age, a sharp
signiﬁcant increase in total distance traveled was found in TrkbPENK-KO mice compared with that in TrkbPENK-WT littermates by 9M of age until later in life
(two-way ANOVA, F(1,42)¼8.964; P¼0.0046, main effect of genotype; F(2,42)¼ 6.406; P¼0.0037, interaction between genotype and age, TrkbPENK-KO
versus TrkbPENK-WT, *P¼0.0001); values are means±s.e.m. (b) Cocaine-induced hyperlocomotion. After 2 days of habituation to the apparatus, mice
(TrkbPENK-WT, n¼ 11; TrkbPENK-KO, n¼ 10) were i.p.-injected with either vehicle on day 0, showing no difference between mutants and controls (one-way
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for the three groups, respectively). On day 1, they were habituated to the rotarod apparatus and subjected to three sessions of 3min at 4 r.p.m. constant
speed, separated by 15-min rest intervals. The next day they were placed on the rod accelerating from 4 to 40 rpm for three consecutive sessions
(separated by 5-min intervals). Latency of each animal to fall from the rod was scored. The performance was not signiﬁcantly different between mutants
and controls (two-way ANOVA, F(1,44)¼0.298; P¼0.5878 main effect of genotype; F(2,44)¼0.874; P¼0.4244, interaction between genotype and age;
F(2,44)¼9.702; P¼0.0003 effect of age). Values are means±s.e.m.
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and muscle strength, and in the weight-lifting test to further
ascertain their strength/forepaw grasping. No signiﬁcant differ-
ences were scored between the two genotypes for either test
(Supplementary Fig. S5). Overall, these data reveal subtle changes
in gait parameters in TrkbPENK-KO mice, which are evident before
the appearance of spontaneous altered locomotion.
Reduced ENK expression in striatal MSNs upon Trkb deletion.
To rule out that the phenotype observed in locomotor activity was
not the result of loss or morphological alteration of the ENKþ
MSNs but rather a primary effect of the lack of TrkB signaling in
ENKþMSNs, we ﬁrst examined the relative abundance of striatal
MSNs in aged TrkbPENK-KO mice and TrkbPENK-WT littermates.
Counts of neurons labeled with Abs against an MSN-speciﬁc
marker, like dopamine- and cAMP-regulated phosphoprotein of
32 kDa (DARPP-32), did not reveal loss of striatal MSNs in
TrkbPENK-KO mice compared with TrkbPENK-WT littermates
(Fig. 3a). Stereological analysis of histological sections revealed
normal striatal volume in TrkbPENK-KO compared with that in
TrkbPENK-WT mice at 12M of age (Supplementary Fig. S6a,b).
Computer-based morphometric analysis of Golgi-impregnated
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striatal MSNs showed no difference in dendritic spine density
(Fig. 3c, and Supplementary Fig. S6c) and thickness (Supplementary
Fig. S6d) between 12-M old TrkbPENK-KO mice and TrkbPENK-WT
littermates. Sholl analysis further supported this observation,
revealing no difference in dendritic arbor complexity (Fig. 3d).
Although these morphological data apply to the total MSN
population, there was no evidence for a bimodal distribution,
making unlikely the possibility that defects in ENKþMSNs were
masked by the striatonigral subpopulation. However, striatal
enkephalin expression was reduced in TrkbPENK-KO mice in the
absence of striatal MSN loss or DARPP-32 reduction (Fig. 3b,e,
and Supplementary Fig. S6e). Further analysis of synaptic mar-
kers and dopamine receptors levels in the striatum revealed no
signiﬁcant changes between mutants and controls at 12M of age
(Fig. 3e). These results demonstrate that long-term survival and
morphology of striatopallidal MSNs are not affected by BDNF–
TrkB signaling-speciﬁc inactivation. In contrast, depletion of
TrkB signaling affects striatal enkephalin expression and function
of these neurons, suggesting that signaling activated by BDNF–
TrkB is required in these cells to perform normal inhibitory
function on locomotor activity.
Intact corticostriatal synaptic properties in TrkbPENK-KO mice.
As alterations of the corticostriatal tract are known to affect MSN
physiology and, therefore, locomotor behavior, we examined the
electrophysiological properties of this tract in TrkbPENK-WT and
TrkbPENK-KO mice. Basal glutamatergic synaptic transmission in
slices containing the dorsolateral striatum of TrkbPENK-WT and
TrkbPENK-KO mice was analyzed by extracellular ﬁeld potential
recordings. Input–output relationships were constructed by
plotting the mean amplitude of ﬁeld excitatory postsynaptic
potential (fEPSP) against the increasing stimulation intensities.
There was no signiﬁcant difference in the input–output curves or
in the amplitude of the fEPSPs between TrkbPENK-WT and mutant
mice (Fig. 4a). To determine whether ablation of Trkb from
striatopallidal neurons would affect neurotransmitter release from
presynaptic terminals at corticostriatal synapses, we measured
responses to paired-pulse stimulation at 40 and 60ms interpulse
intervals, whose ratio is considered as an index of release prob-
ability, a form of short-term synaptic plasticity. Paired-pulse
responses had similar amplitude between TrkbPENK-WT and
TrkbPENK-KO mice, and similar ratio values (Fig. 4b). We also
examined another crucial parameter of basal glutamatergic
transmission, namely, the spontaneous activity of MSNs. Inter-
estingly, no signiﬁcant differences in frequency or amplitude of
the spontaneous postsynaptic currents were found in ENKþ
MSNs between controls and mutants (Fig. 4c). Collectively, these
ﬁndings indicate that basal excitatory synaptic transmission and
short-term plasticity at the corticostriatal synapses are similar in
the two genotypes. However, these data do not rule out the
possibility that lack of BDNF/TrkB signaling in striatopallidal
neurons would lead to other electrophysiological changes.
TrkB signaling modulates striatopallidal MSN activation. As
Trkb deletion in ENKþMSNs results in spontaneous and drug-
induced hyperlocomotion, we next asked if TrkB signaling in
these neurons would interfere with dopamine/D2R function that
represses striatopallidal MSNs excitability in response to gluta-
matergic cortical input. Therefore, we combined precise mouse
genetics with a pharmacological approach, and determined
whether loss of Trkb speciﬁcally from D2R/ENK-positive MSNs
would impair the response of these cells upon acute excitatory
effect induced by D2R blockade. We performed D2 receptor
blockade using a D2R-like antagonist (haloperidol)31, which
triggers an acute excitatory effect of striatopallidal MSNs. This is
followed by neuronal activation and c-Fos induction
predominantly in D2R neurons31. Accordingly, TrkbPENK-WT
and TrkbPENK-KO animals were injected either with 1mg kg 1
haloperidol or vehicle (DMSO), and the density of c-Fos-
immunoreactive (c-Fos-ir) cells in the caudate-putamen was
determined after 2 h by immunohistochemistry. The results
showed a signiﬁcant reduction in the density of haloperidol-
induced c-Fos-ir cells in TrkbPENK-KO mice compared with that in
TrkbPENK-WT (Fig. 5a,c). These data indicate that Trkb-depleted
striatopallidal MSNs are not able to respond efﬁciently to the
excitatory effect induced by D2R blockade, suggesting that TrkB
signaling modulates activation of striatopallidal MSNs integrating
cortical glutamatergic input.
To further support the observations obtained in the dorsal
striatum, we also assessed the ability of haloperidol to activate
D2R/ENKþ (PV-) MSNs in the LGP of TrkbPENK-KO mice
and TrkbPENK-WT by similar analysis of c-Fos-ir expression in
response to D2R blockade. These cells project to the striatum and
form the pallidostriatal pathway32. The results obtained 2 h after
haloperidol injection show a signiﬁcant reduction in the density
of haloperidol-induced c-Fos-ir cells in TrkbPENK-KO mice
compared with that in TrkbPENK-WT (Fig. 5b,d,e,f). These data
indicate impaired feedback of PV-negative LGP cells to striatal
neurons. This effect was similar to that observed in the
striatopallidal MSNs of the indirect pathway, and indicates that
TrkB signaling is required in these cells for their normal activation.
Intact striatopallidal projections in the absence of TrkB. To
analyze if reduced activation of the striatopallidal neurons would
affect targeting of striatopallidal projections in the LGP, we
analyzed the density of GABAergic synapses on PVþ LGP
neurons, which are part of the indirect pathway and receive direct
striatopallidal projections33. Densities of pre- and postsynaptic
GABAergic components were analyzed by immunostaining of the
presynaptic enzymes glutamic acid decarboxylase 67 (GAD67)
and the postsynaptic scaffolding protein gephyrin, respectively.
The imaging at single-cell level of PV-expressing pallidal
cells paired with 3D computer-based reconstruction of the
immunostaining allowed detailed analysis of the GABAergic
striatopallidal terminations. Quantiﬁcation of either gephyrin- or
GAD67-containing synapses on PV-labeled neurons in the LGP
of haloperidol-treated TrkbPENK-WT and TrkbPENK-KO mice
revealed no signiﬁcant difference in the somatodendritic density
of both GAD67 and gephyrin (Fig. 6a–d). These data indicate
that absence of TrkB signaling does not affect targeting
of striatopallidal projections and/or synaptic density on LGP
PVþ neurons.
TrkB modulates D2R-dependent striatal PKC and MAPK
activation. It has been shown that D2 receptor agonists lead
to MAPK phosphorylation in neurons through increased
intracellular Ca2þ and PKC activity34. Striatal activation of
ERK is necessary for the expression of D2 receptor-mediated
locomotor hyperactivity35. Therefore, to provide a possible
mechanistic insight into our novel ﬁndings, we have tested the
effect of TrkB signaling depletion on the activation of these
kinases in 13-M-old TrkbPENK-KO striatum, when mutants
already show spontaneous hyperlocomotion, and in 5-M-old,
a presymptomatic stage. We found signiﬁcantly enhanced
phosphorylation of both PKC and ERK1/2 in TrkbPENK-KO
mice compared with that in TrkbPENK-WT at 13M of age, but
no signiﬁcant difference in AKT or DARPP-32 (Thr34)
phosphorylation (Fig. 7a,c). The enhanced phosphorylation of
PKC and MAPKs was not evident in TrkbPENK-KO mice at 5M
of age, suggesting that aging is a critical factor (Fig. 7b,d). To
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test whether the increased phosphorylation state of PKC
and ERK1/2 was D2R-dependent, we challenged 13-M-old
TrkbPENK-KO mice and TrkbPENK-WT with a more selective
antagonist of the D2R (L-741,626) (ref. 36). This treatment
blocked the increased phosphorylation of PKC and ERK1/2 in
TrkbPENK-KO mice (Fig. 7a,c), indicating that increased PKC/MAPK
phosphorylation is the result of enhanced D2R-signaling in the
absence of TrkB signaling.
Discussion
The speciﬁc depletion of TrkB signaling from mouse striatopallidal
neurons, while maintaining cerebral cortex TrkB expression, has
allowed to investigate the physiological role of BDNF–TrkB
signaling in ENKþMSNs and to determine whether the known
effects of altered cortical BDNF signaling on striatal vulnerability
are mediated via TrkB. Here, we show that TrkB signaling is
required to control inhibition of locomotor behavior in ENKþ
MSNs. Ablation of Trkb from striatopallidal MSNs results in
spontaneous and drug-induced hyperlocomotion associated with
reduced enkephalin expression and increased D2R-dependent
striatal PKC and MAPKs phosphorylation, leading to altered
response of ENKþMSNs to glutamate-mediated excitation.
However, long-term survival and morphology of ENKþMSNs
were not affected. Finally, these data identify a critical role for
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Figure 4 | Functional integrity of the corticostriatal pathway in TrkbPENK-KO mice. (a) Averaged fEPSP traces (upper panel) evoked by a stimulation
of 12, 16, 22, 28, 32 and 36 V. Input–output best-ﬁt curves (lower panel) revealed no signiﬁcant difference between TrkbPENK-WT (n¼ 7 slices/4 mice)
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stimulation. (b) Histograms of group data showing similar paired-pulse ratio (PPR) of responses at 40 and 60ms of interpulse intervals stimulation
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TrkB signaling in locomotor behavior exerted by ENK striato-
pallidal neurons and demonstrate that these neurons are not
dependent on BDNF–TrkB signaling for long-term survival and
morphology in vivo.
BDNF is a major regulator of neuronal survival and
morphology. One current main hypothesis suggests that a
reduction in cortical BDNF and/or impairment in BDNF
anterograde transport from cortex to striatal targets contribute
to the degeneration of striatal neurons observed both in patients
and in HD animal models37. This suggestion, however, is based
mainly on genetic models that compromise cerebral cortex
physiology, and do not allow direct evaluation of the contribution
of BDNF–TrkB signaling to striatal vulnerability. Therefore, to
address the physiological role of BDNF–TrkB signaling in
striatopallidal neurons, the most vulnerable neuronal subtype
in HD3, we have selectively deleted the high-afﬁnity BDNF
receptor, TrkB, from these neurons. Our data indicate that
BDNF–TrkB signaling is required to control inhibition of
locomotor behavior, but is not an essential factor for long-term
survival and maintenance of ENK MSNs, and does not have a
direct role in the striatal vulnerability observed upon cortical
deletion of Bdnf. These contradictory roles for BDNF may be
explained by its necessity for the maintenance of cortical neuron
morphology. In particular, forebrain-speciﬁc conditional deletion
of Bdnf leads to a reduction in cellular size and dendritic
complexity of pyramidal neurons in cortical layer II–III at just 3
weeks of age38. This, and possible alteration of other cortical
layers, could compromise cortical input to striatal targets leading
to the observed morphological changes in striatal MSNs14.
Therefore, in contrast to the current belief14,39, our data
support the theory that complex alteration of the corticostriatal
tract, and/or cortical cell-intrinsic properties ultimately contribute
to striatal vulnerability. Indeed, dysfunction of the corticostriatal
tract seems to occur during the development of the HD phenotype
before any signiﬁcant neuronal cell loss is apparent in the
striatum40–43. In our mouse model, we found functional integrity
of the corticostriatal tract analyzed by electrophysiology. The
procedure we have used (fEPSP) has been shown to be sensitive
and reliable for detecting alterations in the electrophysiological
properties of MSN subpopulations44.
Unexpectedly, disruption of TrkB signaling in ENKþMSNs
induces spontaneous hyperlocomotion, suggesting that TrkB in
striatopallidal neurons contributes to the inhibitory control of
locomotor behavior exerted by the indirect pathway. Notably
ablation of D2R neurons in the entire striatum produced a bigger
hyperlocomotor response than when ablation was limited to
ventral striatum only25. This is in agreement with the current
hypothesis of the BG identifying striatopallidal MSNs as an
inhibitory component of the circuit controlling motor activity45.
Particularly noteworthy is that conditional inactivation of TrkB
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signaling in striatopallidal MSNs leads to a reduction of
enkephalin, one of the earliest morphological changes observed
in HD3,46, without affecting MSN viability. The decrease in
enkephalin expression presumably reﬂects a reduction in
neuronal activity of the striatopallidal efferents projecting to the
external globus pallidus. This could affect the identity of
MSN belonging to the indirect pathway, compromising their
functionality and consequently causing an increase of spontaneous
and cocaine-associated activity by disinhibition of the striatopallidal
projections. Indeed, a similar phenotype occurs by conditional
deletion of DARPP-32 in striatopallidal MSNs. This leads to
increased basal and cocaine-induced locomotor activity in the
presence of a compromised corticostriatal LTP without any cell
loss26. In our model, however, since cortical Trkb has been left
mainly intact, the functional integrity of the corticostriatal
pathway is not affected and the inhibitory function observed
is therefore mainly conﬁned to the striatopallidal pathway.
Recent studies though, showed that mice carrying deletion of
Trkb mediated by a less-restricted Cre line (D2R-Cre)47, have
decreased locomotor activity upon cocaine administration
without signiﬁcant changes of c-Fos-ir in the dorsal striatum
upon acute cocaine treatment48. This inconsistency with our
study may be due to D2R expression in both striatopallidal
MSNs and striatal cholinergic interneurons47, unlike enkephalin.
Therefore, considering the modulatory activity of striatal cholinergic
cells over the striatopallidal pathway49,50, it is not surprising that
the opposite result was obtained in the activation of striatopallidal
neurons and, therefore, in the behavioral output.
It is evident from the classical BG model10 that normal
locomotor behavior results from the balance between direct and
indirect BG pathways. Recently, this model has also been
supported by the use of optogenetics51. Moreover, D2R activation
reduces indirect pathway excitability speciﬁcally induced by
cortical afferent activation and subsequent Ca2þ inﬂow52.
Diminished D2R or a D2R blockade leads to an excess of
Ca2þ inﬂow, hence increasing indirect pathway activation.
Essentially, D2R activation represses striatopallidal MSNs
excitability by inhibiting calcium entry in these neurons
through modulation of NMDAR and R-type Ca2þ channels.
This effect is, in part, compensated by A2AR activation, which
enhances Ca2þ entry52. In our model, striatopallidal MSNs
carrying TrkB depletion are not able to respond efﬁciently to
the acute excitatory effect induced by D2R-like antagonist
haloperidol (measured by c-Fos induction). The observed
reduced enkephalin expression in these neurons also supports
this ﬁnding. This suggests that TrkB signaling modulates
activation of striatopallidal MSNs, integrating cortical glutamatergic
input, most likely by enhancing Ca2þ entry to compensate for
the dopamine/D2R repression of glutamatergic input, therefore
maintaining physiological balance of GABAergic transmission.
In addition, we found that major manifestation of phenotypes,
such as hyperlocomotion, is noticeable with age or by challenges
such as cocaine administration in young mutant animals. One
possible explanation for this is that during aging there is a
progressive decline in brain production of neurotrophic factors
and their cognate receptors. In the BG of young animals, the
presence of a signiﬁcant amount of trophic factors may be able
to compensate for the deﬁcit caused by the absence of TrkB
signaling. With aging, the availability of trophic factors declines,
exacerbating the deﬁcit caused by the absence of TrkB.
Epigenetic changes occurring with aging could also explain the
appearance of the phenotype only in older animals.
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Figure 6 | Unchanged synaptic density in striatopallidal targets in the absence of presynaptic BDNF–TrkB signaling. (a,b) Single-cell level
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Finally, Trkb-speciﬁc deletion in ENKþMSNs demonstrates
that in physiological conditions, BDNF signaling is not required
for the long-term survival and morphology of these striatal
neurons. It does, however, affect enkephalin expression and
neuronal activity resulting in altered locomotion. As reduced
levels of BDNF in a diseased brain exacerbate the severity of
motor dysfunction5, its replacement should maintain normal
cortical physiology, and, therefore, also ameliorate striatal
physiology by re-establishing enkephalin levels and neuronal
activity, and thus improve motor behavior8. Our data do not
exclude the possibility that the concomitant absence of BDNF–
TrkB signaling in the presence of mutant huntingtin in striatal
MSNs could instead have a deleterious effect on striatal neuron
physiology. These ﬁndings have obvious relevance given potential
therapeutic approaches to HD.
Methods
Ethics statement. All animal procedures at the European Molecular Biology
Laboratory (Mouse Biology Unit) conformed to National and International laws
and policies (EEC Council Directive 86/609, OJ L 358, 1, 12 December 1987; NIH
Guide for the Care and Use of Laboratory Animals, NIH Publication No. 85-23,
1985, revised in 1995); at the Centre for Neuroregeneration and at the Department
of Pharmacology, animal procedures conformed to UK legislation (Scientiﬁc
procedures) ACT 1986, the University of Edinburgh and the University of Oxford
ethical review committee policy, respectively.
Immunohistochemistry. Immunohistochemistry was performed as previously
described23. Primary Abs were used at the following dilution: Ctip2 (1:1,000,
ab18465, Abcam), DARPP-32 (1:500, AB1656, Chemicon), EGFP (1:500, ab290,
Abcam), c-Fos (1:500, sc-52, Santa Cruz Biotechnology), enkephalin (1:200,
RA14124, Neuromics), ChAt (1:1,000, ab1449, Chemicon), Calretinin (1:1,000,
7699/4, Swant), Somatostatin (1:200, ab5494, Chemicon), Parvalbumin (1:1,000,
P3088, Sigma, rabbit polyclonal), GAD67 (1:2,000, Millipore) and gephyrin (1:500,
Synaptic System). Alexa-labeled secondary Abs (1:1,000 Invitrogen), or biotin-
conjugated anti-rabbit Ab (1:500 Jackson Lab). All ﬂuorescent images were taken
on LSM710 Meta confocal microscope (Carl Zeiss) mounting 40x/0.75 NA, and
 63/1.4 NA planapochromat objectives (Carl Zeiss). Bright ﬁeld images were
taken using Axio Scope (Carl Zeiss) mounting  20/0.8 NA and  40/0.75 NA
planapochromat objectives (Carl Zeiss), coupled with an Axio Cam ICC1 color
camera (Carl Zeiss).
Striatal cell counts. The total number of striatal MSNs deﬁned by ﬂuorescent
DARPP-32 expression and in situ labeled enkephalin-expressing MSNs
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Figure 7 | ENK-speciﬁc Trkb deletion affects striatal D2R-dependent PKC and ERK1/2 phosphorylation. (a,b) Representative immunoblots of
proteins extracted from dorsal striatum of 13-M- and 5-M-old TrkbPENK-WT and TrkbPENK-KO mice. Animals were either treated with vehicle or with a
D2R-speciﬁc antagonist L-741,626 (20mg/kg), and killed 30min later. Phosphorylation states of ERK1/2, PKC, AKTand DARPP-32 were determined using
phospho-speciﬁc Abs. See also Supplementary Fig. S8b–c. (c) Graphs represent the phosphorylation state of each protein normalized to its total amount.
Fold changes were determined against vehicle-treated TrkbPENK-WT (set as 1), (vehicle: TrkbPENK-KO versus TrkbPENK-WT, pERK1/2, P¼0.020; p-PKC,
P¼0.028; p-DARPP32, P¼0.065; pAKT, P¼0.17), (L-741,626: TrkbPENK-KO versus TrkbPENK-WT, pERK1/2, P¼0.07; p-PKC, P¼0.19), (L-741,626
treated TrkbPENK-KO versus vehicle treated TrkbPENK-KO, pERK1/2, P¼0.016; p-PKC, P¼0.026). P-values were generated by unpaired Student’s t-test.
Values are means±s.e.m., n¼ 6 per genotype (three per condition) analyzed. (d) Graphs represent the phosphorylation state of each protein normalized to
its total amount at 5M of age. Total DARPP-32 was normalized to ERK1. Fold changes were determined against vehicle-treated TrkbPENK-WT (set as 1),
(vehicle: TrkbPENK-KO versus TrkbPENK-WT, pERK1/2, P¼0.06; p-PKC, P¼0.90; DARPP-32, P¼0.33). P-values were generated by unpaired Student’s
t-test. Values are means±s.e.m., n¼ 5 per group analyzed.
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(Supplementary Methods) were estimated using design-based stereology with the
optical fractionator method as described by Gundersen et al.53 Sequential sagittal
sections with a thickness of 30mm spanning the entire medio-lateral extension of
one brain hemisphere were obtained at the cryostat (Leica Microsystems). One in
every 12 sections were counted with an unbiased counting frame size 50 30 mm
for DARPP-32 and 100 100mm for Enk. The frames were randomly positioned
by the ‘Unbiased counting frame’ macro of ImageJ (v1.46r, NIH) with a regular
distance between frames of x¼ 300mm, y¼ 280 mm for DARPP-32 and
x¼ 330 mm, y¼ 300mm for Enk. The heights of the dissectors were of 8 and 15 mm
with a guard of 4 and 2 mm on either side, respectively (Supplementary Fig. 7). Cells
in each frame were counted complying with the optical fractionator counting rules.
Striatal boundaries were deﬁned using the following morphological references: the
corpus callosum, the external capsule, the lateral ventricle and the anterior
commissure.
Morphological analysis of MSNs including spine density. The morphological
analysis of striatal neurons was based on previously described Golgi–Cox
impregnation method reported to be highly sensitive for detecting morphological
alteration of striatal cells8. More details are reported in Supplementary Methods.
Haloperidol treatment. Three-month-old TrkbPENK-KO and TrkbPENK-WT mice
were intraperitoneally (i.p.) injected with 1mg kg 1 haloperidol (H1512, Sigma) or
vehicle (DMSO), and 2 h later, were euthanatized, perfused transcardially and
processed for immunohistochemistry as described above.
L-741,626 treatment. 13-M-old mutants and controls were either i.p.-injected
with 20mg kg 1 L-741,626 or with vehicle (DMSO), and 30min later, animals
were killed by cervical dislocation and striata were dissected, followed by protein
lysate preparation and immunoblots, as described below.
Immunoblotting. Protein lysates from adult controls and mutant mouse brains
were obtained by dissection of the cortex and striatum. Tissues were homogenized
in 10 volumes of (vol/wt) lysis buffer (150mM NaCl, 50mM Tris pH 8.0,
1%(vol/vol) NP-40, 0.1%(wt/vol) SDS plus a cocktail of protease inhibitors, Sigma)
by a glass dounce (VWR), followed by mild sonication. Total protein lysate (30 mg)
were then subjected to SDS–PAGE. After transfer onto nitrocellulose membranes
(GE healthcare), membranes were probed with Ab against TrkB (1:500, 80E3, Cell
Signaling), Synaptophysin (1:10,000, Sy-Sy), PSD-95 (1:1,000, Millipore),
Neuroligin-2 (1:500, Sy-Sy), GAD67 (1:1,000, Millipore), DARPP-32 (1:2,000,
Millipore), D2R (1:200, Millipore), D1R (1:200, Millipore), ERK (1:1,000, Zymed),
PKCconsensus (1:1,000, Calbiochem), AKT (1:1,000, Cell Signaling), GAPDH
(1:10,000, Sigma) or TUJ.1 (1:10,000, Abcam); for the detection of phosphorylated
proteins, membranes were incubated with Abs from Cell Signaling against p-PKC
(pan, Thr514), pMAPK (Erk1/2) (Thr202/Tyr204), p-DARPP-32 (Thr34), p-AKT
(Ser473), followed by incubation with HRP-conjugated secondary Ab (1:10,000,
Jackson Lab). Images were visualized by using SuperSignal West Pico
Chemiluminescent Substrate System (Pierce) and BioMax Light Films (Kodak).
Behavioral analysis. The body weights of mice involved in the behavioral tests
were noted before every task.
OF: spontaneous locomotor activity was assessed by analyzing exploratory
behavior of 2–14-month-old mice of both sexes in a 50 50 28 cm open arena
(TSE, Germany) illuminated with 100 lux and coupled with an automated video
tracking system (VideoMot, TSE). Each mouse was placed in the center of the ﬁeld,
and allowed to explore the arena freely for 30min. For the experiments addressing
cocaine-induced locomotion, mice were weighed before every session in order to
determine the amount of drug to deliver. Animals on day  1 were placed in the
arena and left to habituate to the apparatus for 30min; on day 0, mice were
subjected to a second habituation session immediately after i.p. vehicle injection
(NaCl, 0.9% wt/vol). In the subsequent 3 days, cocaine-paired sessions were
performed after i.p. injection of 10mg kg 1 of cocaine hydrochloride (Sigma)
dissolved in 0.9% NaCl solution, following the same procedure. The time spent in
the center (arbitrarily deﬁned as 34 34 cm square inside the OF) of the arena and
the total distance traveled were measured. The average across the 3 cocaine-
conditioned days is reported.
The accelerating rotarod system was used to assess motor coordination
(Advanced System, TSE). On day 1, 2–14-month-old mice of both sexes were
habituated to the apparatus by subjecting them to three sessions of 3min at 4 r.p.m.
constant speed, separated by 15-min rest intervals. The next-day performance was
tested by placing mice on the rod accelerating from 4 to 40 r.p.m. (over a 5-min
interval). Mice were scored for the latency to fall during the trials. The average
latency of the three trials for each animal was then calculated.
For the inverted screen test, 5-month--old mice of both sexes were placed in the
center of a screen (20.5 13 cm-wire mesh, 12mm2 holes), and the screen was
inverted over a 2-s period with the mouse’s head declining. The screen was held
steadily 90 cm above a solid, cushioned surface. Latency to fall was noted with
cutoff time at 90 s.
For the weight-lifting/grip strength test, 5-month-old mice of both sexes
were held by the tail and lowered to grasp a scale collector (a ball of tangled ﬁne
stainless steel wire, 7 g) attached to increasing lengths of steel chain made up of
13 g links. Each mouse was then raised for 3 s, supporting the weight with its
forepaws. Mice were allowed to rest for 5min before progressing to the next heavier
weight. If the mouse dropped the weight immediately, it was tested again 10 s
later. Failure at the second trial terminated the test. Maximum weight supported
by the mouse for 3 s was used as a measure of strength.
Detailed analysis of gait was performed using the CatWalk system (Noldus, the
Netherlands) according to the previously published method28,29,54. Runs were
recorded using a camera (GEViCAM Inc., USA). Details of the general parameters
measured and analyzed are reported in Supplementary Methods.
Electrophysiological experiments. The electrophysiological recordings were
performed according to Calabresi et al.55 Adult male mice (5–9 months) were used
for all the experiments. Details are reported in the Supplementary Methods.
Statistical analysis. Two-way ANOVA using either age and genotype, or den-
dritic order and genotype as independent variables, was used for the data analysis
of the rotarod, and spontaneous locomotion or spine density and dendritic
thickness, respectively. One-way ANOVA was used to determinate signiﬁcance
between different genotypes in Sholl analysis and for cocaine-induced locomotion
analysis. In case of signiﬁcant difference among the means, a post hoc Fisher PLSD
test was performed and the P-value was reported. Cell counts, synaptic density, WB
analysis, locomotion of BAC–PENKtg/þ , electrophysiological data, and behavioral
data for the CatWalk, inverted screen and grip strength were analyzed by two-
tailed unpaired Student’s t-test. All tests of signiﬁcance were performed at a¼ 0.05
using Unistat 5.6 (Unistat Ltd, London, UK).
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